daunorubicin has been researched along with cp 65,526 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arceci, RJ; Bierer, BE; Stieglitz, K | 1 |
| Gottesman, MM; Hrycyna, CA; Pastan, I; Ramachandra, M | 1 |
2 other study(ies) available for daunorubicin and cp 65,526
| Article | Year |
|---|---|
Immunosuppressants FK506 and rapamycin function as reversal agents of the multidrug resistance phenotype.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Binding, Competitive; Daunorubicin; Drug Resistance; Drug Synergism; Humans; Iodine Radioisotopes; Membrane Glycoproteins; Phenotype; Polyenes; Prazosin; Sirolimus; Tacrolimus; Tumor Cells, Cultured | 1992 |
Functional expression of human P-glycoprotein from plasmids using vaccinia virus-bacteriophage T7 RNA polymerase system.
Topics: Adenosine Triphosphatases; Affinity Labels; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Cell Membrane; Cloning, Molecular; Colchicine; Daunorubicin; Dihydropyridines; DNA-Directed RNA Polymerases; Drug Resistance, Multiple; Electrophoresis, Polyacrylamide Gel; Escherichia coli; HeLa Cells; Humans; Indicators and Reagents; Iodine Radioisotopes; Osteosarcoma; Plasmids; Polymerase Chain Reaction; Prazosin; Recombinant Proteins; Restriction Mapping; Transfection; Tritium; Tumor Cells, Cultured; Vaccinia virus; Vinblastine; Viral Proteins | 1998 |